Detailed answers about NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED, including incorporation, status, business activity, and accounts information.
When was NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED founded?
NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED was officially incorporated on 5 April 2025 and is registered under company number 16367413. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED?
NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED do?
NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED's registered address?
The registered office address of NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED is 23 CHORLEYS LANE, WIDNES, ENGLAND, WA8 3HS. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED financially stable?
Financial accounts for NEUROAFFIRMATIVE CONSULTANCY & MORE LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.